Eliem Therapeutics to Host Virtual Investor Event on July 21, 2022

SEATTLE and CAMBRIDGE, United Kingdom, July 07, 2022 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (NASDAQ:ELYM ), a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems, today announced it will host a virtual investor event on Thursday, July 21, 2022 starting at 10:30 a.m. ET. Eliem's virtual investor event will include presentations from Bob Azelby, president and chief executive officer and Valerie Morisset, Ph.D., executive vice president, R&D and chief scientific officer as well as a presentation from opinion leader John D. Markman, M.D., Vice ... Full story available on Benzinga.com